Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 Gag protein (Group-specific antigen) is a polyprotein essential for virion assembly, genome packaging, and budding from the host cell membrane. It comprises several domains (MA, CA, NC, SP1, SP2, p6) that are cleaved by the viral protease during maturation to produce infectious virions. Gag is an important antiretroviral target.
Inhibition of virion assembly, maturation, or release
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Group-specific Antigen (None).